Tuesday, September 17, 2013

FT - Novartis’s Alcon embroiled in Chinese corruption allegations By Patti Waldmeir in Shanghai

Alcon, the eyecare division of Novartis, said it would investigate claims that it used fake clinical trials to bribe doctors in China, the latest in what has become a steady stream of corruption allegations against mostly foreign pharmaceutical companies in China.


No comments: